<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32934824</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2059-9781</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2020</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of systems and integrative neuroscience</Title><ISOAbbreviation>J Syst Integr Neurosci</ISOAbbreviation></Journal><ArticleTitle>Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.15761/JSIN.1000228</ELocationID><Abstract><AbstractText>In the face of the global pandemic of COVID 19, approaching 1.75 Million infected worldwide (4/12/2020) and associated mortality (over 108, 000 as of 4/12/2020) as well-as other catastrophic events including the opioid crisis, a focus on brain health seems prudent [1] (https://www.coronavirus.gov). This manuscript reports on the systemic benefits of restoring and achieving dopamine homeostasis to reverse and normalize thoughts and behaviors of Reward Deficiency Syndrome (RDS) dysfunctional conditions and their effects on behavioral physiology; function of reward genes; and focuses on digestive, immune, eye health, and the constellation of symptomatic behaviors. The role of nutrigenomic interventions on restoring normal brain functions and its benefits on these systems will be discussed. We demonstrate that modulation of dopamine homeostasis using nutrigenomic dopamine agonists, instead of pharmaceutical interventions, is achievable. The allied interlinking with diverse chronic diseases and disorders, roles of free radicals and incidence of anaerobic events have been extensively highlighted. In conjunction, the role of dopamine in aspects of sleep, rapid eye movement and waking are extensively discussed. The integral aspects of food indulgence, the influence of taste sensations, and gut-brain signaling are also discussed along with a special emphasis on ocular health. The detailed mechanistic insight of dopamine, immune competence and the allied aspects of autoimmune disorders are also highlighted. Finally, the integration of dopamine homeostasis utilizing a patented gene test and a research-validated nutrigenomic intervention are presented. Overall, a cutting-edge nutrigenomic intervention could prove to be a technological paradigm shift in our understanding of the extent to which achieving dopamine homeostasis will benefit overall health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Downs</LastName><ForeName>B W</ForeName><Initials>BW</Initials><AffiliationInfo><Affiliation>Department of Nutrigenomics Research, Victory Nutrition International, Inc., Lederach, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blum</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nutrigenomics Research, Victory Nutrition International, Inc., Lederach, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Western University, Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Addiction Research, Pathway Healthcare, Birmingham, AL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eotvos Lor&#xe1;nd University, Institute of Psychology, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, Dayton, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Precision Nutrition, GARS IP., LLC, Hollywood Fl., USA, &amp; Geneus Health, LLC., San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagchi</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nutrigenomics Research, Victory Nutrition International, Inc., Lederach, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological &amp; Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushner</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ALM Research &amp; Development, Oldsmar, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagchi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dr. Herbs LLC, Concord, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvin</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Vitality Medical Wellness Institute, PLLC, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>McG</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Anatomy &amp; Psychiatry, Howard University, School of Medicine, Washington, D., USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siwicki</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Precision Nutrition, GARS IP., LLC, Hollywood Fl., USA, &amp; Geneus Health, LLC., San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brewer</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Precision Nutrition, GARS IP., LLC, Hollywood Fl., USA, &amp; Geneus Health, LLC., San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyett</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Addiction Research, Pathway Healthcare, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baron</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Western University, Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute of Holistic and Addiction Studies, Davie, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badgaiyan</LastName><ForeName>R D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, ICHAN School of Medicine, Mount Sinai, New York, NYC. &amp; Department of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, San Antonio, TX, Long School of Medicine, University of Texas Medical Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 CX000479</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073884</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R41 MD012318</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Syst Integr Neurosci</MedlineTA><NlmUniqueID>101671495</NlmUniqueID><ISSNLinking>2059-9781</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaerobic</Keyword><Keyword MajorTopicYN="N">dopamine</Keyword><Keyword MajorTopicYN="N">dopamine homeostasis</Keyword><Keyword MajorTopicYN="N">hypoxic</Keyword><Keyword MajorTopicYN="N">neurotrophic</Keyword><Keyword MajorTopicYN="N">reward deficiency syndrome</Keyword></KeywordList><CoiStatement>Conflicts of interest Kenneth Blum, PhD assigned his IP to GARS IP, LLC., Hollywood Florida. Drs. Blum and Brewer are paid employees of GARS IP, LLC., and Geneus Health, LLC.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32934824</ArticleId><ArticleId IdType="mid">NIHMS1595404</ArticleId><ArticleId IdType="pmc">PMC7489293</ArticleId><ArticleId IdType="doi">10.15761/JSIN.1000228</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center for Disease Control and Prevention (CDC). Coronavirus (COVID-19) (https://www.coronavirus.gov) (accessed
Mar 25, 2020).</Citation></Reference><Reference><Citation>Velavan TP, Meyer CG (2020) The COVID-19 epidemic. Trop Med Int Health 25: 278&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169770</ArticleId><ArticleId IdType="pubmed">32052514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer B, Pang M, Jones W (2020) The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis? Subst Abuse Treat Prev Policy 15: 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7027114</ArticleId><ArticleId IdType="pubmed">32066470</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoller JW (2016) The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology 41: 297&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4677147</ArticleId><ArticleId IdType="pubmed">26321314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranzler HR, Zhou H, Kember RL, Vickers Smith R, Justice AC, et al. (2019) Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun 10: 1499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445072</ArticleId><ArticleId IdType="pubmed">30940813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilverstand A, Huang AS, Alia-Klein N, Goldstein RZ (2018) Neuroimaging impaired response inhibition and salience attribution in human drug addiction: A systematic review. Neuron 98: 886&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995133</ArticleId><ArticleId IdType="pubmed">29879391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman G, Shaltiel G, Barbash S, Cohen J, Gasho CJ, et al. (2012) Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NF&#x3ba;B pathway. Transl Psychiatry 2: e78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3309554</ArticleId><ArticleId IdType="pubmed">22832815</ArticleId></ArticleIdList></Reference><Reference><Citation>Plein LM, Rittner HL (2018) Opioids and the immune system - friend or foe. Br J Pharmacol 175: 2717&#x2013;2725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016673</ArticleId><ArticleId IdType="pubmed">28213891</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Briggs AH, Trachtenberg MC, Delallo L, Wallace JE, et al. (1987) Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice. Alcohol 4: 449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">2829941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Wallace JE, Briggs AH, Trachtenberg MC (1985) Evidence for the importance of the &#x201c;genotype&#x201d; theory in alcohol seeking behavior: a commentary. Alcohol Drug Res 6: 455&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">3015159</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovi&#x107; BD, Radulovi&#x107; J (1992) Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 67: 241&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">1305637</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Chen ALC, Thanos PK (2018) Genetic addiction risk score (GARS)&#x2122;, a predictor of vulnerability to opioid dependence. Front Biosci (Elite Ed) 10: 175&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28930612</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Modestino EJ, Neary J (2018) Promoting precision addiction management (PAM) to combat the global opioid crisis. Biomed J Sci Tech Res 2: 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6201280</ArticleId><ArticleId IdType="pubmed">30370423</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Madigan MA, Fried L, Braverman ER, Giordano J, et al. (2017) Coupling genetic addiction risk score (GARS) and pro dopamine regulation (KB220) to combat substance use disorder (SUD). Glob J Addict Rehabil Med 1: 555556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5796781</ArticleId><ArticleId IdType="pubmed">29399668</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Modestino EJ, Gondre-Lewis M (2017) Dopamine homeostasis requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America&#x2019;s drug epidemic. J Syst Integr Neurosci 3: 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128292</ArticleId><ArticleId IdType="pubmed">30197787</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs BW, Blum K, Baron D (2019) Death by Opioids: Are there non-addictive scientific solutions? J Syst Integr Neurosci 5: 1&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6904107</ArticleId><ArticleId IdType="pubmed">31824737</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried L, Modestino EJ, Siwicki D, Lott L, Thanos PK, et al. (2019) Hypodopaminergia and &#x201c;Precision Behavioral Management&#x201d; (PBM): It is a generational family affair. Curr Pharm Biotechnol.</Citation><ArticleIdList><ArticleId IdType="pubmed">31820688</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Modestino EJ, Lott L (2018) Introducing &#x201c;Precision Addiction Management (PAM&#xae;)&#x201d; as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America. Open Access J Behav Sci Psychol 1: 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6335959</ArticleId><ArticleId IdType="pubmed">30662982</ArticleId></ArticleIdList></Reference><Reference><Citation>Abijo T, Blum K, Gondre-Lewis MC (2019) Neuropharmacological and neurogenetic correlates of opioid use disorder (OUD) as a function of ethnicity: Relevance to precision addiction medicine. Curr Neuropharmacol.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457418</ArticleId><ArticleId IdType="pubmed">31744450</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Gold M, Modestino EJ, Baron D, Boyett B, et al. (2018) Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS&#xae;) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)? J Syst Integr Neurosci 4: 1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865059</ArticleId><ArticleId IdType="pubmed">31750006</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Baron D, McLaughlin T, Gold MS (2020) Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). J Neurol Sci 411: 116733.</Citation><ArticleIdList><ArticleId IdType="pubmed">32088516</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Modestino EJ, Gondr&#xe9;-Lewis MC, Neary J, Siwicki D, et al. (2017) Global opioid epidemic: doomed to fail without genetically based precision addiction medicine (Pam&#x2122;): Lessons learned from America. Precis Med (Bangalore) 2: 17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5778881</ArticleId><ArticleId IdType="pubmed">29372187</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, et al. (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263: 2055&#x2013;2060.</Citation><ArticleIdList><ArticleId IdType="pubmed">1969501</ArticleId></ArticleIdList></Reference><Reference><Citation>American society of addiction medicine (ASAM). Public policy statement; Definition of addiction, 2019, https://www.asam.org/resources/definition-of-addiction (Accessed
Mar 15, 2020).</Citation></Reference><Reference><Citation>Lipner LM, Mendelsohn R, Muran JC (2017) Psychoanalysis. In: The SAGE encyclopedia of abnormal and clinical psychology. Ed. Wenzel A. SAGE Publications, Inc., Thousand Oaks, CA, pp. 2709&#x2013;2711.</Citation></Reference><Reference><Citation>Oesterle TS, Thusius NJ, Rummans TA, Gold MS (2019) Medication-assisted treatment for opioid-use disorder. Mayo Clin Proc 94: 2072&#x2013;2086.</Citation><ArticleIdList><ArticleId IdType="pubmed">31543255</ArticleId></ArticleIdList></Reference><Reference><Citation>National alliance on mental illness. NAMI Hernando. https://namihernando.org/ (accessed
Mar 16, 2020).</Citation></Reference><Reference><Citation>Koehl JL, Zimmerman DE, Bridgeman PJ (2019) Medications for management of opioid use disorder. Am J Health Syst Pharm 76: 1097&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pubmed">31361869</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Thompson B, Demotrovics Z, Femino J, Giordano J, et al. (2015) The molecular neurobiology of twelve steps program &amp; fellowship: Connecting the dots for recovery. J Reward Defic Syndr 1: 46&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4545669</ArticleId><ArticleId IdType="pubmed">26306329</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbier JR, Downs BW, Kushner S, Aloisio T, Bagchi D, et al. (2019) VMP35 MNC, a novel iron-free supplement, enhances cytoprotection against anemia in human subjects: a novel hypothesis. Food Nutr Res 63: 3410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6510707</ArticleId><ArticleId IdType="pubmed">31105509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagchi D, Garg A, Krohn RL, Bagchi M, Bagchi DJ, et al. (1998) Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 19930: 771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559333</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs BW, Bagchi M (2017) A hidden etiological nemesis of chronic neurodegenerative diseases. In: Phytopharmaceuticals for brain health. Eds: Subhan S, Bagchi M. CRC Press/Taylor &amp; Francis Group, Boca Raton, FL, Chapter 1: 3&#x2013;16.</Citation></Reference><Reference><Citation>Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, et al. (2017) Enhanced functional connectivity and volume between cognitive and reward centers of na&#xef;ve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS One 12: e0174774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405923</ArticleId><ArticleId IdType="pubmed">28445527</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Liu Y, Wang W, Wang Y, Zhang Y, et al. (2015) rsfMRI effects of KB220Z&#x2122; on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgrad Med 127: 232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4979602</ArticleId><ArticleId IdType="pubmed">25526228</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu WM, Xu XH, Yan MM, Wang YQ, Urade Y, et al. (2010) Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 30: 4382&#x2013;4389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6634511</ArticleId><ArticleId IdType="pubmed">20335474</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti JM, Jantos H (2008) The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 172: 625&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">18772053</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Oscar-Berman M, Badgaiyan RD, Khurshid KA, Gold MS, et al. (2014) Dopaminergic neurogenetics of sleep disorders in reward deficiency syndrome (RDS). J Sleep Disord Ther 3: 126&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4314958</ArticleId><ArticleId IdType="pubmed">25657892</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Kang H, Xu Q, Chen MJ, Liao Y, et al. (2013) Sleep drives metabolite clearance from the adult brain. Science 342: 373&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880190</ArticleId><ArticleId IdType="pubmed">24136970</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin T, Febo M, Badgaiyan RD, Barh D, Dushaj K, et al. (2016) K. KB220Z&#x2122; a pro-dopamine regulator associated with the protracted, alleviation of terrifying lucid dreams. Can we infer neuroplasticity-induced changes in the reward circuit? J Reward Defic Syndr Addict Sci 2: 3&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5308138</ArticleId><ArticleId IdType="pubmed">28210713</ArticleId></ArticleIdList></Reference><Reference><Citation>Landolt HP (2011) Genetic determination of sleep EEG profiles in healthy humans. Prog Brain Res 193: 51&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">21854955</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst SC, Bersagliere A, Bachmann V, Berger W, Achermann P, et al. (2014) Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci 4: 566&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608156</ArticleId><ArticleId IdType="pubmed">24403155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieroni MA (2019) Investigation of apomorphine during sleep in Parkinson&#x2019;s improvement in UPDRS Scores. Neurol Int 11: 8207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6908956</ArticleId><ArticleId IdType="pubmed">31871600</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL, et al. (2018) Bidirectional neural interaction between central dopaminergic and gut lesions in parkinson&#x2019;s disease models. Mol Neurobiol 55: 7297&#x2013;7316.</Citation><ArticleIdList><ArticleId IdType="pubmed">29404956</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs BW, Corbier JR, Speight N, Kushner S, Aloisio T, et al. (2020) Anemia: Influence of dietary fat, sugar, and salt on hemoglobin and blood health. In: Dietary sugar, salt, and fat in human health. In: Dietary sugar, salt, and fat in human health.</Citation></Reference><Reference><Citation>Sclafani A, Ackroff K (2012) Role of gut nutrient sensing in stimulating appetite and conditioning food preferences. Am J Physiol Regul Integr Comp Physiol 302: 1119&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3362145</ArticleId><ArticleId IdType="pubmed">22442194</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BJ, Cote PD, Tremblay F (2015) Dopamine modulation of rod pathway signaling by suppression of GABAC feedback to rod-driven depolarizing bipolar cells. Eur J Neurosci 42: 2258&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pubmed">26080286</ArticleId></ArticleIdList></Reference><Reference><Citation>Felder-Schmittbuhl MP, Buhr ED, Dkhissi-Benyaha O, Hicks D, Pierson SN, et al. (2018) Ocular clocks: Adapting mechanisms for eye functions and health. Invest Opthalmol Vis Sci 59: 4856&#x2013;4870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181243</ArticleId><ArticleId IdType="pubmed">30347082</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Oscar-Berman M, Badgaiyan R, Braverman ER, Gold MS, et al. (2014) Hypothesizing darkness induced alcohol intake linked to dopaminergic regulation of brain function. Psychology (Irvine) 5: 282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4083566</ArticleId><ArticleId IdType="pubmed">25009759</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamini G, Mechtersheimer J, Azzinnari D, Sigirst H, Buerge M, et al. (2018) Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice. Neurobiol Stress 8: 42&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991330</ArticleId><ArticleId IdType="pubmed">29888303</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, et al. (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. (2010) Nature Medicine 16: 279&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3556275</ArticleId><ArticleId IdType="pubmed">20190767</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE, et al. (2001) Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol 23: 117&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">11331109</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki N, Abijo T, Galvao C, Darius P, Blum K, et al. (2020) Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats. Behavioral Brain Res 385: 112563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244251</ArticleId><ArticleId IdType="pubmed">32070691</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Trachtenberg MC, Elliott CE, Dingler ML, Sexton RL, et al. (1988) Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE. Alcohol 5: 481&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">3072969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagchi D, Misner B, Bagchi M, Kothari SC, Downs BW, et al. (2002) Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: A mechanistic exploration. Intl J Clin Pharmacol Res 22: 101&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">12837047</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba VV, Zandman-Goddard G, Shoenfeld Y (2019) Prolactin and autoimmunity: The hormone as an inflammatory cytokine. Best Pract Res Clin Endocrinol Metab 11: 101324.</Citation><ArticleIdList><ArticleId IdType="pubmed">31564625</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS, et al. (2014) genetic addiction risk score (GARS): Molecular neurogenetic evidence for predisposition to reward deficiency syndrome (RDS). Molecular Neurobiology 50: 765&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225054</ArticleId><ArticleId IdType="pubmed">24878765</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Giordano J, Morse S, Liu Y, Tan J, et al. (2010) Research: Pharmacogenomics genetic addiction risk score (GARS) analysis: Exploratory development of polymorphic risk alleles in poly-drug addicted males. The IIOAB 1: 1&#x2013;14</Citation></Reference><Reference><Citation>Blum K, Oscar-Berman M, DiNubile N, Giordano J, Braverman ER, et al. (2013) Coupling genetic addiction risk score (GARS) with electrotherapy: Fighting iatrogenic opioid dependence. J Addict Res Ther 4: 1000163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3946872</ArticleId><ArticleId IdType="pubmed">24616834</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Chen ALC, Thanos PK, Febo M, Demetrovics Z, et al. (2018) Genetic addiction risk score (GARS) &#x2122;, a predictor of vulnerability to opioid dependence. Front Biosci (Elite Ed) 10: 175&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28930612</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs BW, Blum K, Baron D, Bowirrat A, Lott L, et al. (2019) Death by opiods: Are there non-addictive scientific solutions? J Syst Integr Neurosci 5: 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6904107</ArticleId><ArticleId IdType="pubmed">31824737</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorrock HK, van der Hoorn D, Boyd PJ, Liavero-Hurtado M, Lamont DJ, et al. (2018) UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy. Brain 141: 2878&#x2013;2894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158753</ArticleId><ArticleId IdType="pubmed">30239612</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Baron D, McLaughlin T, Gold MS (2020) Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). J Neurol Sci 411: 116733.</Citation><ArticleIdList><ArticleId IdType="pubmed">32088516</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Siwicki D, Baron D, Modestino EJ, Badgaiyan RD, et al. (2018) The benefits of genetic addiction risk score (GARSTM) and pro-dopamine regulation in combating suicide in the American Indian population. J Syst Integr Neurosci 4: 1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6816273</ArticleId><ArticleId IdType="pubmed">31660252</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K, Gondr&#xe9;-Lewis MC, Baron D, Thanos PK, Braverman ER, et al. (2018) Introducing precision addiction management of reward deficiency syndrome, the construct that underpins all addictive behaviors. Front Psychiatry 9: 548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277779</ArticleId><ArticleId IdType="pubmed">30542299</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum K (2009) Genes &amp; happiness. Gene Ther Mol Biol 13.</Citation></Reference><Reference><Citation>Stern C (1973) Principles of human genetics. W.H. Freedman, San Fransico.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>